NCT07772492 clinical trial report covering Upadacitinib hemihydrate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07772921 clinical trial report covering Tilrekimig, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07775300 clinical trial report covering Brenipatide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07776509 clinical trial report covering AZD6234, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07775404 clinical trial report covering Elecoglipron, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07777822 clinical trial report covering Zoldonrasib, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07775287 clinical trial report covering Petosemtamab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07776873 clinical trial report covering Recombinant human prourokinase, Phase 3, endpoints, sponsor, geography, readout timing and development white spa

NCT07776691 clinical trial report covering Raludotatug deruxtecan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07778316 clinical trial report covering TARLATAMAB-DLLE, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07777263 clinical trial report covering Goserelin Acetate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07775339 clinical trial report covering Lerodalcibep, Phase 3, endpoints, sponsor, geography, readout timing and development white space.